A Tumor Immune Biomarker Guided Approach for Improving Response to BCG in Patients With High-risk NMIBC.

Clinical trial NCT07064863 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07064863
Sponsor: Queen's University
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

NMIBC Non-Muscle Invasive Bladder Urothelial Carcinoma Bladder (Urothelial, Transitional Cell) Cancer Urothelial Carcinoma Bladder

Start date: 2025-08-01
Primary completion: 2027-07-31
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.